Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. 1977

D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 1985, Materia medica Polona. Polish journal of medicine and pharmacy,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 1988, European journal of clinical pharmacology,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 1990, Pharmacotherapy,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
October 1998, Journal of veterinary pharmacology and therapeutics,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 1988, Clinical pharmacy,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
February 2008, Journal of veterinary pharmacology and therapeutics,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 1977, Antimicrobial agents and chemotherapy,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
January 2011, Veterinary journal (London, England : 1997),
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
August 2017, Journal of veterinary pharmacology and therapeutics,
D J Greenblatt, and H J Pfeifer, and H R Ochs, and K Franke, and D S MacLaughlin, and T W Smith, and J Koch-Weser
September 2023, Poultry science,
Copied contents to your clipboard!